Development, Vol 117, Issue 3 823-833, Copyright © 1993 by Company of Biologists

JOURNAL ARTICLES

Sequences 5' of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development

RR Behringer, DA Crotty, VM Tennyson, RL Brinster, RD Palmiter and DJ Wolgemuth
Laboratory of Reproductive Physiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104.

The murine homeobox-containing gene Hox-1.4 is expressed in restricted patterns during embryogenesis and in male germ cells. To begin identification of the cis-acting elements regulating this expression, transgenic mice were generated carrying a chimeric construct that contained approx. 4 kb of 5' flanking sequence and approx. 1 kb of structural gene, fused in frame to the E. coli lacZ gene. This construct directed expression of the resulting Hox-1.4,beta-galactosidase fusion protein in a pattern that reproduced virtually the complete embryonic and adult sites of expression of the endogenous gene. Embryonic expression of the fusion protein was first detected in mesoderm at day 8.0 of gestation (E 8.0). Between gestational ages E 8.5 to E 12.5, beta-gal expression was observed in the somites, the lateral walls of the posterior myelencephalon, the dorsal region and ventral wall of the spinal cord, spinal ganglia and prevertebrae and their surrounding mesenchyme, between presumptive ribs, as well as in mesenchymal layers in the lung, kidney and portions of the gut. Expression was also noted in the pancreas and in the supporting cells and sheath around subsets of peripheral nerves, sites that had not been detected previously. Adult expression was observed in testes, specifically in meiotic and post-meiotic male germ cells. In contrast, transgenic mice carrying 5' deletions of the construct which leave approx. 1.2 kb or approx. 2.0 kb of Hox-1.4 sequence 5' to the embryonic promoter, did not exhibit beta-gal staining. These deletion experiments defined at least one cis-acting control element necessary for the expression of the Hox-1.4 gene to a 2 kb region located 2 to 4 kb 5' of the embryonic transcription start site.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Minoux, G. S. Antonarakis, M. Kmita, D. Duboule, and F. M. Rijli Rostral and caudal pharyngeal arches share a common neural crest ground pattern Development, February 15, 2009; 136(4): 637 - 645. [Abstract] [Full Text] [PDF]

				M. R. Barron, N. S. Belaguli, S. X. Zhang, M. Trinh, D. Iyer, X. Merlo, J. W. Lough, M. S. Parmacek, B. G. Bruneau, and R. J. Schwartz Serum Response Factor, an Enriched Cardiac Mesoderm Obligatory Factor, Is a Downstream Gene Target for Tbx Genes J. Biol. Chem., March 25, 2005; 280(12): 11816 - 11828. [Abstract] [Full Text] [PDF]

				S. Tabaries, J. Lapointe, T. Besch, M. Carter, J. Woollard, C. K. Tuggle, and L. Jeannotte Cdx Protein Interaction with Hoxa5 Regulatory Sequences Contributes to Hoxa5 Regional Expression along the Axial Skeleton Mol. Cell. Biol., February 15, 2005; 25(4): 1389 - 1401. [Abstract] [Full Text] [PDF]

				K. M. Lele and D. J. Wolgemuth Distinct Regions of the Mouse Cyclin A1 Gene, Ccna1, Confer Male Germ-Cell Specific Expression and Enhancer Function Biol Reprod, October 1, 2004; 71(4): 1340 - 1347. [Abstract] [Full Text] [PDF]

				H. W. Chaudhry, N. H. Dashoush, H. Tang, L. Zhang, X. Wang, E. X. Wu, and D. J. Wolgemuth Cyclin A2 Mediates Cardiomyocyte Mitosis in the Postmitotic Myocardium J. Biol. Chem., August 20, 2004; 279(34): 35858 - 35866. [Abstract] [Full Text] [PDF]

				T. Brend, J. Gilthorpe, D. Summerbell, and P. W. J. Rigby Multiple levels of transcriptional and post-transcriptional regulation are required to define the domain of Hoxb4 expression Development, June 15, 2003; 130(12): 2717 - 2728. [Abstract] [Full Text] [PDF]

				V. Lambert, C. Munaut, P. Carmeliet, R. D. Gerard, P. J. Declerck, A. Gils, C. Claes, J.-M. Foidart, A. Noel, and J.-M. Rakic Dose-Dependent Modulation of Choroidal Neovascularization by Plasminogen Activator Inhibitor Type I: Implications for Clinical Trials Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2791 - 2797. [Abstract] [Full Text] [PDF]

				J. Rautava, T. Soukka, K. Heikinheimo, P.J. Miettinen, R.-P. Happonen, and P. Jaakkola Different Mechanisms of Syndecan-1 Activation through a Fibroblast-growth-factor-inducible Response Element (FiRE) in Mucosal and Cutaneous Wounds Journal of Dental Research, May 1, 2003; 82(5): 382 - 387. [Abstract] [Full Text] [PDF]

				O. Beltcheva, S. Kontusaari, S. Fetissov, H. Putaala, P. Kilpelainen, T. Hokfelt, and K. Tryggvason Alternatively Used Promoters and Distinct Elements Direct Tissue-Specific Expression of Nephrin J. Am. Soc. Nephrol., February 1, 2003; 14(2): 352 - 358. [Abstract] [Full Text] [PDF]

				V. Lambert, C. Munaut, M. Jost, A. Noel, Z. Werb, J.-M. Foidart, and J.-M. Rakic Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization Am. J. Pathol., October 1, 2002; 161(4): 1247 - 1253. [Abstract] [Full Text] [PDF]

				L. DEVY, S. BLACHER, C. GRIGNET-DEBRUS, K. BAJOU, V. MASSON, R. D. GERARD, A. GILS, G. CARMELIET, P. CARMELIET, P. J. DECLERCK, et al. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J, February 1, 2002; 16(2): 147 - 154. [Abstract] [Full Text] [PDF]

				V. LAMBERT, C. MUNAUT, A. NOEL, F. FRANKENNE, K. BAJOU, R. GERARD, P. CARMELIET, M. P. DEFRESNE, J.-M. FOIDART, and J.-M. RAKIC Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization FASEB J, April 1, 2001; 15(6): 1021 - 1027. [Abstract] [Full Text] [PDF]

				M. Kmita, F. van der Hoeven, J. Zákány, R. Krumlauf, and D. Duboule Mechanisms of Hox gene colinearity: transposition of the anterior Hoxb1 gene into the posterior HoxD complex Genes & Dev., January 15, 2000; 14(2): 198 - 211. [Abstract] [Full Text]

				S. A. Rivkees, M. Chen, J. Kulkarni, J. Browne, and Z. Zhao Characterization of the Murine A1 Adenosine Receptor Promoter, Potent Regulation by GATA-4 and Nkx2.5 J. Biol. Chem., May 14, 1999; 274(20): 14204 - 14209. [Abstract] [Full Text] [PDF]

				C. Munaut, T. Salonurmi, S. Kontusaari, P. Reponen, T. Morita, J.-M. Foidart, and K. Tryggvason Murine Matrix Metalloproteinase 9 Gene. 5'-UPSTREAM REGION CONTAINS CIS-ACTING ELEMENTS FOR EXPRESSION IN OSTEOCLASTS AND MIGRATING KERATINOCYTES IN TRANSGENIC MICE J. Biol. Chem., February 26, 1999; 274(9): 5588 - 5596. [Abstract] [Full Text] [PDF]

				J. Reecy, X Li, M Yamada, F. DeMayo, C. Newman, R. Harvey, and R. Schwartz Identification of upstream regulatory regions in the heart-expressed homeobox gene Nkx2-5 Development, January 2, 1999; 126(4): 839 - 849. [Abstract] [PDF]

				Y. Yamazaki, H. Fujimoto, H. Ando, T. Ohyama, Y. Hirota, and T. Noce In Vivo Gene Transfer to Mouse Spermatogenic Cells by Deoxyribonucleic Acid Injection into Seminiferous Tubules and Subsequent Electroporation Biol Reprod, December 1, 1998; 59(6): 1439 - 1444. [Abstract] [Full Text]

				P. Jaakkola, S. Kontusaari, T. Kauppi, A. Määttä, and M. Jalkanen Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes FASEB J, August 1, 1998; 12(11): 959 - 969. [Abstract] [Full Text]

				A. Packer, D. Crotty, V. Elwell, and D. Wolgemuth Expression of the murine Hoxa4 gene requires both autoregulation and a conserved retinoic acid response element Development, January 6, 1998; 125(11): 1991 - 1998. [Abstract] [PDF]

				Y. Qiu, F. A. Pereira, F. J. DeMayo, J. P. Lydon, S. Y. Tsai, and M.-J. Tsai Null mutation of mCOUP-TFI results in defects in morphogenesis of the glossopharyngeal ganglion, axonal projection, and arborization Genes & Dev., August 1, 1997; 11(15): 1925 - 1937. [Abstract] [Full Text] [PDF]

				A Morrison, L Ariza-McNaughton, A Gould, M Featherstone, and R Krumlauf HOXD4 and regulation of the group 4 paralog genes Development, January 8, 1997; 124(16): 3135 - 3146. [Abstract] [PDF]

				J. G. Bartell, T. Davis, E. J. Kremer, M. J. Dewey, and W. S. Kistler Expression of the Rat Testis-specific Histone H1t Gene in Transgenic Mice J. Biol. Chem., February 23, 1996; 271(8): 4046 - 4054. [Abstract] [Full Text] [PDF]

				L Zeltser, C Desplan, and N Heintz Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity Development, January 8, 1996; 122(8): 2475 - 2484. [Abstract] [PDF]

				A Morrison, M. Moroni, L Ariza-McNaughton, R Krumlauf, and F Mavilio In vitro and transgenic analysis of a human HOXD4 retinoid-responsive enhancer Development, January 6, 1996; 122(6): 1895 - 1907. [Abstract] [PDF]

				C Albanesi, R Geremia, M Giorgio, S Dolci, C Sette, and P Rossi A cell- and developmental stage-specific promoter drives the expression of a truncated c-kit protein during mouse spermatid elongation Development, January 4, 1996; 122(4): 1291 - 1302. [Abstract] [PDF]

				Z F Chen and R R Behringer twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & Dev., March 15, 1995; 9(6): 686 - 699. [Abstract] [PDF]

				R. Kapur, D. Sweetser, B Doggett, J. Siebert, and R. Palmiter Intercellular signals downstream of endothelin receptor-B mediate colonization of the large intestine by enteric neuroblasts Development, January 11, 1995; 121(11): 3787 - 3795. [Abstract] [PDF]

				M Frasch, X Chen, and T Lufkin Evolutionary-conserved enhancers direct region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and Drosophila Development, January 4, 1995; 121(4): 957 - 974. [Abstract] [PDF]

				T Knittel, M Kessel, M. Kim, and P Gruss A conserved enhancer of the human and murine Hoxa-7 gene specifies the anterior boundary of expression during embryonal development Development, January 4, 1995; 121(4): 1077 - 1088. [Abstract] [PDF]

				C. Liao, X. Y. Wang, H. Q. Wei, S. Q. Li, T. Merghoub, P. P. Pandolfi, and D. J. Wolgemuth Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1 PNAS, June 5, 2001; 98(12): 6853 - 6858. [Abstract] [Full Text] [PDF]